{"id": "article-20935_0", "title": "Ehrlichiosis -- Continuing Education Activity", "content": "The Ehrlichia genus consists of several species of obligate intracellular gram-negative bacteria that infect humans and other mammals via tick bite. Clinically, Ehrlichia infections share many symptoms and geographic distribution with rickettsial infections, and thus, one must also consider Ehrlichia infections when evaluating patients with flu-like illnesses in endemic areas. This activity explains when this condition should be considered on a differential diagnosis, articulates how to properly evaluate for this condition, and highlights the role of the interprofessional team in caring for patients with this condition.", "contents": "Ehrlichiosis -- Continuing Education Activity. The Ehrlichia genus consists of several species of obligate intracellular gram-negative bacteria that infect humans and other mammals via tick bite. Clinically, Ehrlichia infections share many symptoms and geographic distribution with rickettsial infections, and thus, one must also consider Ehrlichia infections when evaluating patients with flu-like illnesses in endemic areas. This activity explains when this condition should be considered on a differential diagnosis, articulates how to properly evaluate for this condition, and highlights the role of the interprofessional team in caring for patients with this condition."}
{"id": "article-20935_1", "title": "Ehrlichiosis -- Continuing Education Activity", "content": "Objectives: Apply knowledge of\u00a0the etiology of ehrlichiosis. Determine\u00a0the presentation of ehrlichiosis. Identify\u00a0the treatment options for ehrlichiosis. Communicate\u00a0the importance of enhancing care coordination among the interprofessional team to ensure proper evaluation and management of ehrlichiosis. Access free multiple choice questions on this topic.", "contents": "Ehrlichiosis -- Continuing Education Activity. Objectives: Apply knowledge of\u00a0the etiology of ehrlichiosis. Determine\u00a0the presentation of ehrlichiosis. Identify\u00a0the treatment options for ehrlichiosis. Communicate\u00a0the importance of enhancing care coordination among the interprofessional team to ensure proper evaluation and management of ehrlichiosis. Access free multiple choice questions on this topic."}
{"id": "article-20935_2", "title": "Ehrlichiosis -- Introduction", "content": "The Ehrlichia genus consists of several species of obligate intracellular gram-negative bacteria that infect humans and other mammals via tick bite. Clinically, Ehrlichia infections share many symptoms and geographic distribution with rickettsial infections, and thus, one must also consider Ehrlichia  infections\u00a0when evaluating patients with flu-like illnesses in endemic areas. [1] [2] [3]", "contents": "Ehrlichiosis -- Introduction. The Ehrlichia genus consists of several species of obligate intracellular gram-negative bacteria that infect humans and other mammals via tick bite. Clinically, Ehrlichia infections share many symptoms and geographic distribution with rickettsial infections, and thus, one must also consider Ehrlichia  infections\u00a0when evaluating patients with flu-like illnesses in endemic areas. [1] [2] [3]"}
{"id": "article-20935_3", "title": "Ehrlichiosis -- Etiology", "content": "The genus Ehrlichia includes Ehrlichia chaffeesis , which causes human monocytic ehrlichiosis (HME), and Ehrlichia ewingii , which causes Ehrlichia ewingii ehrlichiosis. Other species within this genus include Ehrlichia canis and Ehrlichia ruminantium, which are predominantly veterinary pathogens but may also occasionally infect humans, and the recently described EMLA ( Ehrlichia muris- like agent), which also has associations with human disease. Ehrlichia are intracellular, gram-negative organisms transmitted via tick bite\u00a0and can replicate in both the tick and the infected host. In addition to humans, other hosts include dogs, cattle, sheep, goats, rodents, and deer.", "contents": "Ehrlichiosis -- Etiology. The genus Ehrlichia includes Ehrlichia chaffeesis , which causes human monocytic ehrlichiosis (HME), and Ehrlichia ewingii , which causes Ehrlichia ewingii ehrlichiosis. Other species within this genus include Ehrlichia canis and Ehrlichia ruminantium, which are predominantly veterinary pathogens but may also occasionally infect humans, and the recently described EMLA ( Ehrlichia muris- like agent), which also has associations with human disease. Ehrlichia are intracellular, gram-negative organisms transmitted via tick bite\u00a0and can replicate in both the tick and the infected host. In addition to humans, other hosts include dogs, cattle, sheep, goats, rodents, and deer."}
{"id": "article-20935_4", "title": "Ehrlichiosis -- Epidemiology", "content": "The frequency of Ehrlichia diagnoses is increasing, possibly due to increased recognition and diagnostic availability\u00a0and the expansion of the regions in\u00a0which the most common tick vector, the Lone Star tick ( Amblyomma americanum ), resides. Most Ehrlichia infections in the United States are due to Ehrlichia chaffeesis , with Ehrlichia ewingii reported less frequently. Ehrlichia infections occur predominantly in areas where the Lone Star tick ( Amblyomma americanum ) is prevalent, such as the South Central United States. According to the Centers for Disease Control and Prevention data, over 30% of reported Ehrlichia infections in the United States\u00a0were from Oklahoma, Missouri, and Arkansas. Infections are reported most commonly during the summer months, coincident with the\u00a0adult and\u00a0nymphal stages of\u00a0the tick life\u00a0cycle in\u00a0which ticks are most likely to bite humans. Infections are also reported most commonly in the elderly. However, children are known to experience milder or subclinical infections, and thus, reports may underrepresent this population. [4] [5]", "contents": "Ehrlichiosis -- Epidemiology. The frequency of Ehrlichia diagnoses is increasing, possibly due to increased recognition and diagnostic availability\u00a0and the expansion of the regions in\u00a0which the most common tick vector, the Lone Star tick ( Amblyomma americanum ), resides. Most Ehrlichia infections in the United States are due to Ehrlichia chaffeesis , with Ehrlichia ewingii reported less frequently. Ehrlichia infections occur predominantly in areas where the Lone Star tick ( Amblyomma americanum ) is prevalent, such as the South Central United States. According to the Centers for Disease Control and Prevention data, over 30% of reported Ehrlichia infections in the United States\u00a0were from Oklahoma, Missouri, and Arkansas. Infections are reported most commonly during the summer months, coincident with the\u00a0adult and\u00a0nymphal stages of\u00a0the tick life\u00a0cycle in\u00a0which ticks are most likely to bite humans. Infections are also reported most commonly in the elderly. However, children are known to experience milder or subclinical infections, and thus, reports may underrepresent this population. [4] [5]"}
{"id": "article-20935_5", "title": "Ehrlichiosis -- Pathophysiology", "content": "Infection with Ehrlichia species begins with the intracellular uptake of the infectious extracellular form of the organism, the elementary body (EB) or dense core (DC). The\u00a0elementary body/dense core\u00a0is then taken up by endocytosis, where the organism replicates and matures to form a reticulate body or reticulate core (RB/RC) and then morula before redifferentiating into an elementary\u00a0body/dense core\u00a0that leaves the infected host cell to spread infection. During this process, Ehrlichia utilizes many immune evasion mechanisms, including suppressing apoptosis of host cells, modulation of chemokine and\u00a0cytokine responses, and down-regulation of\u00a0host pattern recognition receptors that might enable\u00a0clearance of the infection. Ehrlichia preferentially infects peripheral blood leukocytes, with E chaffeensis associated with human monocytic cells, including monocytes and macrophages, and neutrophil infections reported in E ewingii . Multiorgan involvement can occur, with organisms detected in the spleen, lymph nodes, bone marrow, and peripheral blood. The\u00a0clinical manifestations of Ehrlichia infections appear to be due to the host's inflammatory response to the infection rather than direct damage from the bacteria.", "contents": "Ehrlichiosis -- Pathophysiology. Infection with Ehrlichia species begins with the intracellular uptake of the infectious extracellular form of the organism, the elementary body (EB) or dense core (DC). The\u00a0elementary body/dense core\u00a0is then taken up by endocytosis, where the organism replicates and matures to form a reticulate body or reticulate core (RB/RC) and then morula before redifferentiating into an elementary\u00a0body/dense core\u00a0that leaves the infected host cell to spread infection. During this process, Ehrlichia utilizes many immune evasion mechanisms, including suppressing apoptosis of host cells, modulation of chemokine and\u00a0cytokine responses, and down-regulation of\u00a0host pattern recognition receptors that might enable\u00a0clearance of the infection. Ehrlichia preferentially infects peripheral blood leukocytes, with E chaffeensis associated with human monocytic cells, including monocytes and macrophages, and neutrophil infections reported in E ewingii . Multiorgan involvement can occur, with organisms detected in the spleen, lymph nodes, bone marrow, and peripheral blood. The\u00a0clinical manifestations of Ehrlichia infections appear to be due to the host's inflammatory response to the infection rather than direct damage from the bacteria."}
{"id": "article-20935_6", "title": "Ehrlichiosis -- History and Physical", "content": "Patients with Ehrlichia infections, regardless of organism, typically present with fever, malaise, headache, body aches, and chills. Symptoms typically begin\u00a01 to\u00a02 weeks after a tick bite, at a median of\u00a09 days. It is important to collect history regarding travel to endemic areas\u00a0and outdoor activities of patients with these non-specific flu-like symptoms during the summer months. Prompt recognition and treatment of\u00a0ehrlichiosis and other tick-borne illnesses may improve outcomes. Other\u00a0findings may include gastrointestinal symptoms,\u00a0such as nausea, vomiting, diarrhea, and rash. The rash is more\u00a0common in children and typically presents\u00a05 days into illness as a maculopapular rash, petechiae, or diffuse erythema. Cough and respiratory symptoms are more common in adults than in children. Like rickettsial infections, central nervous system involvement can also occur in up to 20% of patients, including meningitis and meningoencephalitis.", "contents": "Ehrlichiosis -- History and Physical. Patients with Ehrlichia infections, regardless of organism, typically present with fever, malaise, headache, body aches, and chills. Symptoms typically begin\u00a01 to\u00a02 weeks after a tick bite, at a median of\u00a09 days. It is important to collect history regarding travel to endemic areas\u00a0and outdoor activities of patients with these non-specific flu-like symptoms during the summer months. Prompt recognition and treatment of\u00a0ehrlichiosis and other tick-borne illnesses may improve outcomes. Other\u00a0findings may include gastrointestinal symptoms,\u00a0such as nausea, vomiting, diarrhea, and rash. The rash is more\u00a0common in children and typically presents\u00a05 days into illness as a maculopapular rash, petechiae, or diffuse erythema. Cough and respiratory symptoms are more common in adults than in children. Like rickettsial infections, central nervous system involvement can also occur in up to 20% of patients, including meningitis and meningoencephalitis."}
{"id": "article-20935_7", "title": "Ehrlichiosis -- History and Physical", "content": "In some patients, symptoms may progress to acute respiratory distress syndrome (ARDS) or a sepsis-like or shock-like presentation with cardiovascular instability and coagulopathy. However, overall mortality is much lower in ehrlichiosis than in rickettsial disease. The Centers for Disease Control and Prevention (CDC) reports 1% to 3% mortality rates since 2000 in patients who present for medical care of ehrlichiosis. Importantly, many patients may be infected with ehrlichiosis but not present for medical evaluation, and thus, this may be an overestimate of mortality. Patients who are immunocompromised, elderly, or have received pretreatment with sulfonamide antibiotics are predisposed to more severe illness. [6] [7] [8] [9]", "contents": "Ehrlichiosis -- History and Physical. In some patients, symptoms may progress to acute respiratory distress syndrome (ARDS) or a sepsis-like or shock-like presentation with cardiovascular instability and coagulopathy. However, overall mortality is much lower in ehrlichiosis than in rickettsial disease. The Centers for Disease Control and Prevention (CDC) reports 1% to 3% mortality rates since 2000 in patients who present for medical care of ehrlichiosis. Importantly, many patients may be infected with ehrlichiosis but not present for medical evaluation, and thus, this may be an overestimate of mortality. Patients who are immunocompromised, elderly, or have received pretreatment with sulfonamide antibiotics are predisposed to more severe illness. [6] [7] [8] [9]"}
{"id": "article-20935_8", "title": "Ehrlichiosis -- Evaluation", "content": "Laboratory findings in ehrlichiosis may include leukopenia, thrombocytopenia, and mild to moderately elevated transaminases. Hyponatremia may also be a finding. In some cases, morulae may be present in the peripheral blood or other body fluids of a patient with ehrlichiosis. However, this is not considered a diagnostic of ehrlichiosis. Cerebrospinal leukocytosis and mildly elevated protein levels may also occur. In most centers, diagnosis of ehrlichiosis occurs via polymerase chain reaction (PCR), which is particularly useful in these infections given their predilection for infecting circulating leukocytes. Treatment with doxycycline can decrease the sensitivity of PCR, so samples should be collected before initiation of treatment if possible without significantly delaying therapy. Serology may also be an option; however, culture is not a routine test to diagnose ehrlichiosis.", "contents": "Ehrlichiosis -- Evaluation. Laboratory findings in ehrlichiosis may include leukopenia, thrombocytopenia, and mild to moderately elevated transaminases. Hyponatremia may also be a finding. In some cases, morulae may be present in the peripheral blood or other body fluids of a patient with ehrlichiosis. However, this is not considered a diagnostic of ehrlichiosis. Cerebrospinal leukocytosis and mildly elevated protein levels may also occur. In most centers, diagnosis of ehrlichiosis occurs via polymerase chain reaction (PCR), which is particularly useful in these infections given their predilection for infecting circulating leukocytes. Treatment with doxycycline can decrease the sensitivity of PCR, so samples should be collected before initiation of treatment if possible without significantly delaying therapy. Serology may also be an option; however, culture is not a routine test to diagnose ehrlichiosis."}
{"id": "article-20935_9", "title": "Ehrlichiosis -- Treatment / Management", "content": "Doxycycline is the preferred drug for the treatment of ehrlichiosis, as well as for rickettsial infection. There is no clinical\u00a0data to support alternative agents for ehrlichiosis, although in vitro studies suggest that rifampin may be an option. However, as there is no\u00a0demonstrated clinical efficacy of rifampin in treating ehrlichiosis and as rifampin has no efficacy against rickettsial infections, which\u00a0can be indistinguishable from ehrlichiosis in the early stages of illness, doxycycline remains the\u00a0drug of\u00a0choice. Patients with ehrlichiosis typically defervesce in 48 to 72 hours after initiation of doxycycline. Treatment courses are typically\u00a05 to\u00a07 days, based on illness severity. Clinical studies have demonstrated that tooth staining\u00a0is a rare cosmetic complication of doxycycline at the doses and duration used to treat ehrlichiosis and rickettsial infections. Concerns regarding age and\u00a0potential tooth staining should not delay treatment with doxycycline in children with suspected ehrlichiosis. There is no recommendation for post-tick bite prophylaxis against ehrlichiosis in\u00a0endemic areas. [10] [11]", "contents": "Ehrlichiosis -- Treatment / Management. Doxycycline is the preferred drug for the treatment of ehrlichiosis, as well as for rickettsial infection. There is no clinical\u00a0data to support alternative agents for ehrlichiosis, although in vitro studies suggest that rifampin may be an option. However, as there is no\u00a0demonstrated clinical efficacy of rifampin in treating ehrlichiosis and as rifampin has no efficacy against rickettsial infections, which\u00a0can be indistinguishable from ehrlichiosis in the early stages of illness, doxycycline remains the\u00a0drug of\u00a0choice. Patients with ehrlichiosis typically defervesce in 48 to 72 hours after initiation of doxycycline. Treatment courses are typically\u00a05 to\u00a07 days, based on illness severity. Clinical studies have demonstrated that tooth staining\u00a0is a rare cosmetic complication of doxycycline at the doses and duration used to treat ehrlichiosis and rickettsial infections. Concerns regarding age and\u00a0potential tooth staining should not delay treatment with doxycycline in children with suspected ehrlichiosis. There is no recommendation for post-tick bite prophylaxis against ehrlichiosis in\u00a0endemic areas. [10] [11]"}
{"id": "article-20935_10", "title": "Ehrlichiosis -- Differential Diagnosis", "content": "The differential diagnoses for\u00a0ehrlichiosis include the following: Bacterial sepsis Endocarditis Hepatitis Influenza Kawasaki disease Leptospirosis Murine typhus Q fever Toxic shock syndrome Typhoid fever", "contents": "Ehrlichiosis -- Differential Diagnosis. The differential diagnoses for\u00a0ehrlichiosis include the following: Bacterial sepsis Endocarditis Hepatitis Influenza Kawasaki disease Leptospirosis Murine typhus Q fever Toxic shock syndrome Typhoid fever"}
{"id": "article-20935_11", "title": "Ehrlichiosis -- Prognosis", "content": "Ehrlichiosis generally responds well when diagnosed and treated promptly, with symptomatic improvement within 24 to 48 hours. However, in those with additional health conditions, severe infection, or who experience a delay in treatment, the disease can be serious or even fatal; this is why empiric therapy of suspected\u00a0ehrlichiosis should commence immediately, even before the finalizing of laboratory results. [12]", "contents": "Ehrlichiosis -- Prognosis. Ehrlichiosis generally responds well when diagnosed and treated promptly, with symptomatic improvement within 24 to 48 hours. However, in those with additional health conditions, severe infection, or who experience a delay in treatment, the disease can be serious or even fatal; this is why empiric therapy of suspected\u00a0ehrlichiosis should commence immediately, even before the finalizing of laboratory results. [12]"}
{"id": "article-20935_12", "title": "Ehrlichiosis -- Complications", "content": "In rare instances, eg, in patients with a weak immune system (as can be the case with HIV or cancer), ehrlichiosis can lead to serious complications. These include: Brain conditions,\u00a0including confusion, seizures, or coma Hemorrhage Heart failure Respiratory failure Kidney failure Septic shock", "contents": "Ehrlichiosis -- Complications. In rare instances, eg, in patients with a weak immune system (as can be the case with HIV or cancer), ehrlichiosis can lead to serious complications. These include: Brain conditions,\u00a0including confusion, seizures, or coma Hemorrhage Heart failure Respiratory failure Kidney failure Septic shock"}
{"id": "article-20935_13", "title": "Ehrlichiosis -- Complications", "content": "These complications may\u00a0require additional treatment, including\u00a0respiratory support, IV fluids, or kidney dialysis.\u00a0Complications are more prevalent\u00a0in the elderly or people with pre-existing health conditions. [13]", "contents": "Ehrlichiosis -- Complications. These complications may\u00a0require additional treatment, including\u00a0respiratory support, IV fluids, or kidney dialysis.\u00a0Complications are more prevalent\u00a0in the elderly or people with pre-existing health conditions. [13]"}
{"id": "article-20935_14", "title": "Ehrlichiosis -- Deterrence and Patient Education", "content": "Patients with\u00a0ehrlichiosis cannot pass the disease on to other humans, but an infected individual indicates the potential for others to contract tick-borne diseases. Therefore, patients must be taught the best practices for tick avoidance and control measures. [14]", "contents": "Ehrlichiosis -- Deterrence and Patient Education. Patients with\u00a0ehrlichiosis cannot pass the disease on to other humans, but an infected individual indicates the potential for others to contract tick-borne diseases. Therefore, patients must be taught the best practices for tick avoidance and control measures. [14]"}
{"id": "article-20935_15", "title": "Ehrlichiosis -- Pearls and Other Issues", "content": "There is no vaccine available for any of the Ehrlichia species. Avoiding tick bites remains the mainstay of prevention, with insect repellents, avoiding high-risk areas, covering all exposed skin, and checking carefully for ticks after outdoor activities in endemic areas. As ehrlichiosis is not transmitted directly person-to-person, no isolation is needed.", "contents": "Ehrlichiosis -- Pearls and Other Issues. There is no vaccine available for any of the Ehrlichia species. Avoiding tick bites remains the mainstay of prevention, with insect repellents, avoiding high-risk areas, covering all exposed skin, and checking carefully for ticks after outdoor activities in endemic areas. As ehrlichiosis is not transmitted directly person-to-person, no isolation is needed."}
{"id": "article-20935_16", "title": "Ehrlichiosis -- Enhancing Healthcare Team Outcomes", "content": "Most patients with Ehrlichia infections present to the emergency department or the primary care provider. Because the symptoms and signs of Ehrlichia infection are not specific, it is essential to consult with an infectious disease expert early on. The infection can involve the skin, CNS, GI tract, and muscle or even present with shock. The Centers for Disease Control and Prevention (CDC) reports 1% to 3% mortality rates since 2000 in patients who present for medical care of ehrlichiosis. Importantly, many patients may be infected with ehrlichiosis but not present for medical evaluation, and thus, this may be an overestimate of mortality. Patients who are immunocompromised, elderly, or have received pretreatment with sulfonamide antibiotics are predisposed to more severe illness", "contents": "Ehrlichiosis -- Enhancing Healthcare Team Outcomes. Most patients with Ehrlichia infections present to the emergency department or the primary care provider. Because the symptoms and signs of Ehrlichia infection are not specific, it is essential to consult with an infectious disease expert early on. The infection can involve the skin, CNS, GI tract, and muscle or even present with shock. The Centers for Disease Control and Prevention (CDC) reports 1% to 3% mortality rates since 2000 in patients who present for medical care of ehrlichiosis. Importantly, many patients may be infected with ehrlichiosis but not present for medical evaluation, and thus, this may be an overestimate of mortality. Patients who are immunocompromised, elderly, or have received pretreatment with sulfonamide antibiotics are predisposed to more severe illness"}
{"id": "article-20935_17", "title": "Ehrlichiosis -- Enhancing Healthcare Team Outcomes", "content": "There is no vaccine available for any of the Ehrlichia species. Avoiding tick bites remains the mainstay of prevention, with insect repellents, avoiding high-risk areas, covering all exposed skin, and checking carefully for ticks after outdoor activities in endemic areas. As ehrlichiosis is not transmitted directly person-to-person, no isolation is needed. [15] [16]", "contents": "Ehrlichiosis -- Enhancing Healthcare Team Outcomes. There is no vaccine available for any of the Ehrlichia species. Avoiding tick bites remains the mainstay of prevention, with insect repellents, avoiding high-risk areas, covering all exposed skin, and checking carefully for ticks after outdoor activities in endemic areas. As ehrlichiosis is not transmitted directly person-to-person, no isolation is needed. [15] [16]"}
{"id": "article-20935_18", "title": "Ehrlichiosis -- Review Questions", "content": "Access free multiple choice questions on this topic. Comment on this article.", "contents": "Ehrlichiosis -- Review Questions. Access free multiple choice questions on this topic. Comment on this article."}